Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Milanfranchi

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Clinical Psychopharmacology|May 1, 1997
A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorderA Milanfranchi, S Ravagli, P Lensi, et al.
Journal of Psychiatric Research|March 27, 1999
Depressive comorbidity of panic, social phobic, and obsessive-compulsive disorders re-examined: is there a bipolar II connection?G Perugi, H S Akiskal, S Ramacciotti, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Comorbidity in obsessive-compulsive disorder: focus on depressionA Milanfranchi, D Marazziti, C Pfanner, et al.
International Clinical Psychopharmacology|September 19, 2000
Risperidone augmentation in refractory obsessive-compulsive disorder: an open-label studyC Pfanner, D Marazziti, L Dell'Osso, et al.
Neuropsychobiology|January 1, 1996
Decreased platelet 3H-paroxetine binding in obsessive-compulsive patientsD Marazziti, A Rossi, A Gemignani, et al.
Pharmacopsychiatry|January 27, 1998
Changes in platelet markers of obsessive-compulsive patients during a double-blind trial of fluvoxamine versus clomipramineD Marazziti, C Pfanner, L Palego, et al.
Journal of Affective Disorders|December 5, 1997
The clinical impact of bipolar and unipolar affective comorbidity on obsessive-compulsive disorderG Perugi, H S Akiskal, C Pfanner, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 5, 1998
Episodic course in obsessive-compulsive disorderG Perugi, H S Akiskal, A Gemignani, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Clinical Psychopharmacology|May 1, 1997
A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorderA Milanfranchi, S Ravagli, P Lensi, et al.
Journal of Psychiatric Research|March 27, 1999
Depressive comorbidity of panic, social phobic, and obsessive-compulsive disorders re-examined: is there a bipolar II connection?G Perugi, H S Akiskal, S Ramacciotti, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
Comorbidity in obsessive-compulsive disorder: focus on depressionA Milanfranchi, D Marazziti, C Pfanner, et al.
International Clinical Psychopharmacology|September 19, 2000
Risperidone augmentation in refractory obsessive-compulsive disorder: an open-label studyC Pfanner, D Marazziti, L Dell'Osso, et al.
Neuropsychobiology|January 1, 1996
Decreased platelet 3H-paroxetine binding in obsessive-compulsive patientsD Marazziti, A Rossi, A Gemignani, et al.
Pharmacopsychiatry|January 27, 1998
Changes in platelet markers of obsessive-compulsive patients during a double-blind trial of fluvoxamine versus clomipramineD Marazziti, C Pfanner, L Palego, et al.
Journal of Affective Disorders|December 5, 1997
The clinical impact of bipolar and unipolar affective comorbidity on obsessive-compulsive disorderG Perugi, H S Akiskal, C Pfanner, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 5, 1998
Episodic course in obsessive-compulsive disorderG Perugi, H S Akiskal, A Gemignani, et al.
Pageof 1